Global Neuroblastoma Network: An international multidisciplinary neuroblastoma tumor board for resource-limited countries
- PMID: 35084087
- DOI: 10.1002/pbc.29568
Global Neuroblastoma Network: An international multidisciplinary neuroblastoma tumor board for resource-limited countries
Abstract
Background: Tumor boards are part of standard care of patients with complex cancers, but appropriate multidisciplinary expertise and infrastructure are often not available in low- and middle-income countries (LMIC) for pediatric cancers, such as neuroblastoma. Our goal was to review results of a Global Neuroblastoma Network (GNN) tumor board accessible to LMIC.
Methods: De-identified clinical cases presented via internet conference during a weekly GNN virtual tumor board from 2010 through 2020 were evaluated in a standardized format, including diagnostic imaging, pathology, therapy information, resource limitations, and questions for discussion. Information summarized included the presentations, a survey of the impact on care, and a resource questionnaire.
Results: Registered GNN participants included 575 individuals from 77 countries, with a median of 39 participants per session. Total 412 cases were presented from 32 countries, including 351 unique neuroblastoma patients, 52 follow-up cases, and nine non-neuroblastoma diagnoses. Twenty-eight educational sessions were presented. Limited critical resources for diagnostics and staging of cases included MYCN analysis (54.7%), metaiodobenzylguanidine (MIBG) scans (38.7%), and International Neuroblastoma Pathology Classification (49%). Therapies were also limited, with markedly decreased use of radiation and autologous stem cell transplant for high-risk cases, and no availability of anti-GD2 antibody in LMIC. Limited sampling with a post-presentation survey showed that 100% found the GNN helpful, and 70% altered the care plan based on the discussion.
Conclusion: This report shows the utility of an international tumor board for LMIC focused on a challenging solid tumor where local expertise may be limited, with international multidisciplinary expert participation and educational sessions.
Keywords: low- and middle-income countries; neuroblastoma; solid tumors; support care; telemedicine.
© 2022 Wiley Periodicals LLC.
References
REFERENCES
-
- National Cancer Institute. Tumor Board Review. NCI Dictionary Web site. NCI; Published 2020. 13 October, 2021, https://www.cancer.gov/publications/dictionaries
-
- Pillay B, Wootten AC, Crowe H, et al. The impact of multidisciplinary team meetings on patient assessment, management and outcomes in oncology settings: a systematic review of the literature. Cancer Treat Rev. 2016;42:56-72.
-
- Thenappan A, Halaweish I, Mody RJ, et al. Review at a multidisciplinary tumor board impacts critical management decisions of pediatric patients with cancer. Pediatr Blood Cancer. 2017;64(2):254-258.
-
- El Saghir NS, Farhat RA, Charara RN, Khoury KE. Enhancing cancer care in areas of limited resources: our next steps. Future Oncol. 2014;10(12):1953-1965.
-
- El Saghir NS, Keating NL, Carlson RW, Khoury KE, Fallowfield L. Tumor boards: optimizing the structure and improving efficiency of multidisciplinary management of patients with cancer worldwide. Am Soc Clin Oncol Educ Book. 2014:e461-e466. https://doi.org/10.14694/edbook_am.2014.34.e461
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical